Wednesday, August 27, 2014 7:52:25 PM
EUGENE SEYMOUR
7:14 PM (35 minutes ago)
to me
At this juncture, no one is going to pay what we're worth. Need to get at least one drug approved which will validate the platform.
We're not unknown to major players around the world
Sent from my iPhone
Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange
On Aug 27, 2014, at 4:28 PM, I wrote:
Dear Gene;
Any nibbles for NNVC?
Ref:
TAKEOVER POSSIBILITIES
The market now hears rumours that at least four international drug groups are stalking a company that is developing an experimental treatment for the deadly ebola virus.
http://www.dailymail.co.uk/money/markets/article-2735978/MARKET-REPORT-Tekmira-high-takeover-tonic-healthcare-sector.html
Hello NanoViricides (NNVC) - how much do you want?
Recent NNVC News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
